Injective Labs' CEO Eric Chen Seeks Momentum with On-Chain Derivatives

Injective Labs' CEO Eric Chen has been working on the Layer 1 blockchain since its inception in 2018. The platform was designed to tackle on-chain derivatives with speed and finality comparable to centralized exchanges.

The native order book, sub-second block times, MEV-resistant batch auctions, and a derivatives settlement layer without AMM dependency were key architectural decisions made by Chen and co-founder Albert Chon. Injective shipped mainnet in November 2021 as a sovereign Cosmos-SDK Layer 1 with its own validator set.

The next leg of the Injective roadmap focuses on turning architectural bets into developer activity, including deeper non-perp use cases for the native order book. The company is also working to absorb buyback supply pressure and establish sustained price strength.